Bronchopulmonary Dysplasia Clinical Trial
Official title:
AD-ON: The Danish Study on Tidal Neonatal Nitrogen Oxide (NO) and Vitamins A and D as Possible Predictors of BPD
Verified date | November 2015 |
Source | Hillerod Hospital, Denmark |
Contact | n/a |
Is FDA regulated | No |
Health authority | Denmark: National Board of Health |
Study type | Observational |
Children born prematurely are of greater risk of developing chronic lung disease
(Bronchopulmonary Dysplasia).
With an increase in the amount of premature children, we expect an increasing number of
children with BPD.
Today we do not have many ways of predicting or treating this condition, and the children
are usually in hospital for several months after birth. Many are dismissed with home oxygen.
Children with BPD are typically often re-submitted to hospital with respiratory disease the
first couple of years, and some of them have problems throughout childhood and into
adulthood.
Other scientists have found a correlation between BPD and Chronic Obstructive Pulmonary
Disease (COPD).
The condition as well as the treatment (steroids), are associated with great risk of adverse
effects as Cerebral Palsy, blindness, deafness and mental retardation.
The investigators wish to find a safe way to identify the children in greater risk of
developing BPD, who could therefore benefit from a more intensive treatment.An early
diagnosis would increase the possibility of predicting the prognosis.
Other studies have proven a connection between both low vitamin A and D and high exhaled
nitrogen oxide (NO) with lung disease.
With this trial the investigators wish to make a reference material for NO and vitamins A
and D in infants admitted to the neonatal department at two hospitals in Denmark, both with
and without treatment with nasal Continuous Positive Airway Pressure.
The investigators furthermore wish to describe an eventual connection between BPD and these
factors by examining a large group of children on 7 specific occasions within the first two
months of life and at a one year follow up.
Status | Completed |
Enrollment | 1500 |
Est. completion date | November 2015 |
Est. primary completion date | November 2015 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | N/A to 2 Days |
Eligibility |
Inclusion Criteria: Cohort inclusion - All term and preterm infants admitted to Neonatal (Intensive) Care Unit. Gestational Age 24-42 weeks. Exclusion Criteria: 1. Children with ciliary dyskinesia, as NO is distinguishable lower in these children. 2. Children who can not cooperate to the examination. 3. Children so dependant on oxygen, that the examination/measurement is not possible. 4. Children with pneumothorax 5. Children having a diagnosed pneumonia verified by tracheal secrete. 6. Children with bigger congenital anomalies |
Observational Model: Cohort, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
Denmark | Neonatal departement GN, Rigshospitalet | Copenhagen | Region H |
Denmark | Children´s Departement, North Zealand Hospital, Hilleroed | Hilleroed | Region H |
Lead Sponsor | Collaborator |
---|---|
Hillerod Hospital, Denmark | Rigshospitalet, Denmark |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Bronchopulmonary Dysplasia | The incidence of BPD and the correlation the the above mentioned biomarkers. | From premature birth to a one year follow up | No |
Primary | Tidal exhaled Nitrogen Oxide | Reference material of tidal expiratory NO in a cohort of neonates admitted to Neonatal Intensive Care Unit and Neonatal Care Unit will be made. All children in the study will be measured on 8 occasions including a one year follow up. Association with Bronchopulmonary Dysplasia (BPD) and the measures above will be noted. |
6-7 measures within the first 2 months of life and at 1 year of age. | No |
Secondary | Vitamin levels | Blood levels of Vitamins A (s-retinol) and D (se-25(OH)D2 and D3) will be measured at 3 preset occasions and at one year follow up, as well as maternal and cord blood at the time of birth. Reference material will be made and association to BPD will be noted. |
From birth to a one year follow up | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04506619 -
Safety and Efficacy Outcomes Following Previously Administered Short-Term Treatment With SHP607 in Extremely Premature Infants
|
||
Completed |
NCT04936477 -
Ventilation-perfusion (V/Q) Ratio and Alveolar Surface Area in Preterm Infants
|
N/A | |
Recruiting |
NCT05285345 -
Implementation of a Consensus-Based Discharge Protocol for Preterm Infants With Lung Disease
|
||
Completed |
NCT03649932 -
Enteral L Citrulline Supplementation in Preterm Infants - Safety, Efficacy and Dosing
|
Phase 1 | |
Terminated |
NCT02524249 -
Early Versus Late Caffeine for ELBW Newborns
|
N/A | |
Completed |
NCT02249143 -
Duration of Continuous Positive Airway Pressure and Pulmonary Function Testing in Preterm Infants
|
N/A | |
Active, not recruiting |
NCT01632475 -
Follow-Up Study of Safety and Efficacy of Pneumostem® in Premature Infants With Bronchopulmonary Dysplasia
|
||
Completed |
NCT01460576 -
Improving Prematurity-Related Respiratory Outcomes at Vanderbilt
|
N/A | |
Completed |
NCT00419588 -
Growth of Airways and Lung Tissues in Premature and Healthy Infants
|
||
Unknown status |
NCT00254176 -
Cysteine Supplementation in Critically Ill Neonates
|
Phase 2/Phase 3 | |
Completed |
NCT00208039 -
Pilot Trial of Surfactant Booster Prophylaxis For Ventilated Preterm Neonates
|
N/A | |
Completed |
NCT00319956 -
Trial II of Lung Protection With Azithromycin in the Preterm Infant
|
Phase 2 | |
Completed |
NCT00006401 -
Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants
|
Phase 3 | |
Terminated |
NCT05030012 -
Maintaining Optimal HVNI Delivery Using Automatic Titration of Oxygen in Preterm Infants
|
N/A | |
Completed |
NCT00006058 -
Study of the Pathobiology of Bronchopulmonary Dysplasia in Newborns
|
N/A | |
Completed |
NCT00005376 -
Premature Birth and Its Sequelae in Women
|
N/A | |
Completed |
NCT00011362 -
Dexamethasone Therapy in VLBW Infants at Risk of CLD
|
Phase 3 | |
Completed |
NCT00004805 -
Study of the Effect of Four Methods of Cardiopulmonary Resuscitation Instruction on Psychosocial Response of Parents With Infants at Risk of Sudden Death
|
N/A | |
Completed |
NCT05152316 -
The Baby Lung Study
|
||
Recruiting |
NCT04821453 -
NAVA vs. CMV Crossover in Severe BPD
|
N/A |